Physician

Nicholas David Shuler, DO

According to 2025 Medicare claims, Nicholas Shuler, DO (NPI: 1790103513) practices hematology/oncology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Cass, MO. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 64012-9998. Shuler is affiliated with the Centrus Health LLC (ACO ID: A5304), participating under the MSSP model.

Shuler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 378 traditional Medicare patients, billed 976 HCPCS/CPT codes, and received $69,773 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,179 prescription claims across 206 beneficiaries totaling $1,981,285 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 24 claims. Open Payments data shows 139 records totaling $2,941. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,457 to $1,981,285. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	119	228	$16,084
2021	326	950	$68,205
2022	390	1,054	$76,363
2023	326	871	$59,789
2024	378	976	$69,773

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	86	$3,457
2016	35	121	$8,818
2017	37	105	$15,020
2018	18	42	$125,139
2019	20	60	$221,659
2020	45	114	$236,564
2021	122	514	$624,132
2022	148	771	$1,062,121
2023	167	896	$1,152,616
2024	206	1,179	$1,981,285

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	24	$1,546
2023	N/R	24	$1,671
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	37	38	$129
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	49	49	$99
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	51	69	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	227	613	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	72	105	$44

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	13	368	$290,981
Jakafi	Ruxolitinib Phosphate	13	390	$272,835
Revlimid	Lenalidomide	12	336	$223,396
Lenalidomide	Lenalidomide	17	476	$211,564
Erleada	Apalutamide	11	330	$161,555

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	139	$2,941	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nicholas David Shuler, DO?

Tedicare shows public-source Medicare data for Nicholas David Shuler, DO (NPI 1790103513), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas David Shuler, DO have ACO affiliation data?

Nicholas David Shuler, DO is shown with ACO affiliation data for Centrus Health LLC (MSSP, ACO ID A5304).

What billing organization is linked to Nicholas David Shuler, DO?

Nicholas David Shuler, DO is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Nicholas David Shuler, DO have Open Payments data?

Nicholas David Shuler, DO has 139 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.